Tuani, Renalyn C.

HRN: 11-89-84  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/21/2025
CEFUROXIME 500MG (TAB)
11/21/2025
11/27/2025
PO
500mg
BID
SP NSVD
Checking Initial Appropriateness 
11/22/2025
CEFUROXIME 1.5GM (VIAL)
11/22/2025
11/24/2025
IV
1.5gm X 3 Doses
Q8hr
UTI
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: